Justin F. Klamerus named EVP, chief medical officer at McLaren Health Care

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Justin F. Klamerus was named executive vice president and chief medical officer at McLaren Health Care. 

He will assume the position previously held by Michael McKenna, McLaren Health Care’s first CMO, who died in May 2022.

Klamerus has served as president of Karmanos Cancer Hospital and Network, a subsidiary of McLaren Health Care, since January 2017.

Klamerus’ history with McLaren began in 2009. He served as the program director of cancer services at McLaren Northern Michigan in Petoskey, MI, before becoming president of the McLaren Cancer Institute. In 2014, when McLaren acquired the Karmanos Cancer Institute, he assumed the role of executive vice president and chief quality officer at Karmanos. He was then named president of the organization.

While at Karmanos, Klamerus oversaw the expansion of the Karmanos Cancer Network and led business and clinical partnerships with community physicians, academic faculty, and graduate medical education partners.

In 2020, Klamerus was appointed to the Public Health Advisory Commission by Michigan Governor Gretchen Whitmer.

Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login